BENDHEIM JACK (President and CEO) sold 23.8% of their position (22.88K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $1.20M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
−5.28K
Price / share
$51.66
Trade value
$272.76K
% of position
Class A Common Stock
Shares
−4.31K
Price / share
$51.80
Trade value
$223.30K
% of position
Class A Common Stock
Shares
−3.60K
Price / share
$53.03
Trade value
$190.82K
% of position
Class A Common Stock
Shares
−2.65K
Price / share
$53.64
Trade value
$142.21K
% of position
Class A Common Stock
Shares
−1.94K
Price / share
$51.78
Trade value
$100.41K
% of position
Class A Common Stock
Shares
−4.98K
Price / share
$52.79
Trade value
$262.72K
% of position
Class A Common Stock
Shares
−124.00
Price / share
$53.24
Trade value
$6.60K
% of position
Net shares
−22.88K
Net value
-$1.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 3/17/2026 | S · Sale | −5.28K | $51.66 | $272.76K | 5.5% | 96.20K | 90.92K |
| Class A Common Stock Indirect | 3/18/2026 | S · Sale | −4.31K | $51.80 | $223.30K | 4.7% | 90.92K | 86.61K |
| Class A Common Stock Indirect | 3/18/2026 | S · Sale | −3.60K | $53.03 | $190.82K | 4.2% | 86.61K | 83.01K |
| Class A Common Stock Indirect | 3/18/2026 | S · Sale | −2.65K | $53.64 | $142.21K | 3.2% | 83.01K | 80.36K |
| Class A Common Stock Indirect | 3/19/2026 | S · Sale | −1.94K | $51.78 | $100.41K | 2.4% | 80.36K | 78.42K |
| Class A Common Stock Indirect | 3/19/2026 | S · Sale | −4.98K | $52.79 | $262.72K | 6.3% | 78.42K | 73.44K |
| Class A Common Stock Indirect | 3/19/2026 | S · Sale | −124.00 | $53.24 | $6.60K | 0.2% | 73.44K | 73.32K |
| Total | −22.88K | -$1.20M | ||||||
Class A Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |